Jindal Drugs Profile
Key Indicators
- Authorised Capital ₹ 27.26 Cr
- Paid Up Capital ₹ 11.96 Cr
- Company Age 42 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 666.00 Cr
- Satisfied Charges ₹ 797.98 Cr
- Revenue Growth -1.61%
- Profit Growth -19.04%
- Ebitda -38.01%
- Net Worth 8.08%
- Total Assets 18.14%
About Jindal Drugs
Jindal Drugs Private Limited (JDPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 04 November 1982 and has a history of 42 years and four months. Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Jindal Dye Intermediate Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 27.26 Cr and a paid-up capital of Rs 11.96 Cr.
The company currently has active open charges totaling ₹666.00 Cr. The company has closed loans amounting to ₹797.98 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ajay Jindal, Shrikrishan Jindal, Krishnabai Jindal, and Three other members serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24114MH1982PTC028621
- Company No.
028621
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Nov 1982
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Chemicals and Materials
Financial Services
Who are the key members and board of directors at Jindal Drugs?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajay Jindal  | Managing Director | 01-Oct-2011 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ishaan Jindal | Director | 08-Jul-2019 | Current |
| Shrikrishan Jindal | Whole-Time Director | 01-Oct-2011 | Current |
| Krishnabai Jindal | Whole-Time Director | 23-Mar-2015 | Current |
| Mamta Jindal | Whole-Time Director | 23-Mar-2015 | Current |
| Aashna Jindal | Whole-Time Director | 24-Oct-2017 | Current |
Financial Performance of Jindal Drugs.
Jindal Drugs Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 1.61% decrease. The company also saw a substantial fall in profitability, with a 19.04% decrease in profit. The company's net worth moved up by a moderate rise of 8.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jindal Drugs?
In 2020, Jindal Drugs had a promoter holding of 98.36% and a public holding of 1.65%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Jindal Multitrade Private LimitedAjay Jindal and Shrikrishan Jindal are mutual person
- Jogmaz Holding And Investments Private Limited
Ajay Jindal and Mamta Jindal are mutual person
- Eskay Management Services Pvt Ltd
Ajay Jindal, Shrikrishan Jindal and 2 more are mutual person
- Jogmaz Organic Industries Private Limited
Ajay Jindal and Mamta Jindal are mutual person
Charges (Loans)
Open Charges
₹666.00 Cr
Satisfied Charges
₹797.98 Cr
Charges Breakdown by Lending Institutions
- Sbicap Trustee Company Limited : 600.00 Cr
- Others : 50.00 Cr
- Oversea- Chinese Banking Corp Ltd : 16.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Oct 2022 | Others | ₹50.00 Cr | Open |
| 25 Mar 2014 | Sbicap Trustee Company Limited | ₹600.00 Cr | Open |
| 19 Jul 1998 | Oversea- Chinese Banking Corp Ltd | ₹8.00 Cr | Open |
| 14 Jul 1998 | Oversea- Chinese Banking Corp Ltd | ₹8.00 Cr | Open |
| 17 Jun 2020 | Others | ₹9.09 Cr | Satisfied |
How Many Employees Work at Jindal Drugs?
Jindal Drugs has a workforce of 47 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jindal Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jindal Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Jindal Drugs
Recent activity within the organization
- Annual General Meeting
Jindal Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Jindal Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
- Charges
A charge registered on 17 Jun 2020 via Charge ID 100344503 with Others was fully satisfied on 11 Jan 2023.
- Charges
A charge with Others amounted to Rs. 50.00 Cr with Charge ID 100653162 was registered on 31 Oct 2022.
- Charges
A charge with Others amounted to Rs. 9.09 Cr with Charge ID 100344503 was registered on 17 Jun 2020.
- Charges
A charge registered on 05 Feb 1996 via Charge ID 90186310 with Idbi Bank was fully satisfied on 08 Nov 2019.
Frequently asked questions
What is the Incorporation or founding date of Jindal Drugs Private Limited?
Jindal Drugs Private Limited was incorporated on 04 Nov 1982.
What is authorized share capital and paid-up capital of Jindal Drugs Private Limited?
The authorized share capital of Jindal Drugs Private Limited is ₹ 27.26 Cr and paid-up capital is ₹ 11.96 Cr.
Who are the current board members & directors of Jindal Drugs Private Limited?
Currently 6 directors are associated with Jindal Drugs Private Limited.
- Ajay Shrikrishan Jindal
- Shrikrishan Parameshwaridas Jindal
- Krishnabai Shrikrishan Jindal
- Mamta Ajay Jindal
- Aashna Ajay Jindal
- Ishaan Jindal
What is the registered address of Jindal Drugs Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Jindal Drugs Private Limited is 12A Bakhtawar 12Th Floor 229 Nariman Point, India, Mumbai, Maharashtra, 400021.
What is the corporate identification number (CIN) and company number of Jindal Drugs Private Limited?
The corporate identification number (CIN) of Jindal Drugs Private Limited is U24114MH1982PTC028621 and the company number is 028621 as per Ministry of Corporate Affairs (MCA).
What is the official website of Jindal Drugs Private Limited?
The Official website of Jindal Drugs Private Limited is https://www.jindaldrugs.com
What has been the recent revenue trend for Jindal Drugs Private Limited?
According to the financial reports for the fiscal year 2020, the revenue trend for Jindal Drugs Private Limited has fallen by -1.61%.
How many employees does Jindal Drugs Private Limited currently have?
As Per 2020 financial reports, 47 employees are currently employed by Jindal Drugs Private Limited.
What change has been observed in the net worth of Jindal Drugs Private Limited, and by what percentage?
The financial reports for the fiscal year 2020 indicates that The net worth of Jindal Drugs Private Limited has experienced an upsurge of 8.08%.
What are the total open charges for Jindal Drugs Private Limited?
As per the financial statements for fiscal Year 2020, The total open charges for Jindal Drugs Private Limited amount to ₹ 666.00 Cr.
When was the last Balance Sheet of Jindal Drugs Private Limited filed with the ROC?
The most recent Balance Sheet for Jindal Drugs Private Limited was filed with the ROC on 31 Mar 2024.
People also Viewed
Sanjay JindalWholetime DirectorVJ
Vijay JindalWholetime DirectorJJ
Jayshree JindalWholetime Director
Similar Companies Based on Diversified Financial Services
Dow Chemical International Private Limited Thane, Maharashtra, India
India Glycols Limited Udham Singh Nagar, Uttarakhand, India
Aarti Industries Ltd Valsad, Gujarat, India
Pidilite Industries Limited Mumbai, Maharashtra, India
Paradeep Phosphates Ltd Khorda, Odisha, India
Tipsons Financial Services Private Limited Ahmedabad, Gujarat, India
Gujarat Alkalies And Chemicals Limited Vadodara, Gujarat, India
Micro Labs Limited Bangaluru, Karnataka, India